Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 1/2006

01-02-2006 | Letter

Prolonged remission in adult-onset Still’s disease with etanercept

Authors: Rakesh Kumari, Sukhbir S. Uppal

Published in: Clinical Rheumatology | Issue 1/2006

Login to get access

Excerpt

Anti-tumor necrosis factor (TNF)-α therapy is being tried in resistant patients with adult-onset Still’s disease (AOSD), but most cases achieve only partial remission [1, 2]. We describe a Kuwaiti man with early resistant AOSD who achieved complete remission with etanercept, but relapsed when it was discontinued 2 years later and who again showed full clinical response upon its reintroduction. …
Literature
1.
Fautrel B, Sibilia J, Mariette X, Combe B (2004) Tumor necrosis factor (alpha) blocking agents in refractory adult Still’s disease: an observational study of 20 cases. Ann Rheum Dis 64:262–266
2.
Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM, Weinblatt ME (2002) Etanercept in the treatment of adult patients with Still’s disease. Arthritis Rheum 46:1171–1176
3.
Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P, Prost A (1995) Epidemiology of adult Still’s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 54:587–590
4.
Cush JJ, Medsger TA Jr, Christy WC, Herbert DC, Cooperstein LA (1987) Adult-onset Still’s disease. Clinical course and outcome. Arthritis Rheum 30:186–194
5.
Uppal SS, Pande IR, Kumar A, Kailash S, Sekharan NG, Adya CM, Malaviya AN (1995) Adult-onset Still’s disease in northern India: comparison with juvenile onset Still’s disease. Br J Rheumatol 34:429–434
6.
Caramaschi P, Biasi D, Carletto A, Bambara LM (2002) A case of adult-onset Still’s disease treated with infliximab. Clin Exp Rheumatol 20:113
7.
Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C (2001) Infliximab in the treatment of adult Still’s disease refractory to conventional therapy. Clin Exp Rheumatol 19:329–332
8.
Kokkinos A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP (2004) Successful treatment of refractory adult-onset Still’s disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 23:45–49
9.
Kraetsch HG, Antoni C, Kalden JR, Manger B (2001) Successful treatment of a small cohort of patients with adult-onset of Still’s disease with infliximab: first experiences. Ann Rheum Dis 60 [Suppl 3]:iii55–iii57
10.
Olivieri I, de Stefano G, Padula A, La Gala A, de Stefano C (2003) Infliximab in a case of early adult-onset Still’s disease. Clin Rheumatol 22:369–370
11.
Asherson RA, Pascoe L (2002) Adult-onset Still’s disease: response to Enbrel. Ann Rheum Dis 61:859–860
12.
Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A (2002) Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept. Drug Saf 25:173–197
13.
Dechant C, Schauenberg P, Antoni CE, Kraetsch HG, Kalden JR, Manger B (2004) Longterm outcome of TNF blockade in adult-onset Still’s disease. Dtsch Med Wochenschr 129:1308–1312
14.
Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430
15.
Hench PK (1989) Evaluation and differential diagnosis of fibromyalgia. Approach to diagnosis and management. Rheum Dis Clin North Am 15:19–29
16.
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172
Metadata
Title
Prolonged remission in adult-onset Still’s disease with etanercept
Authors
Rakesh Kumari
Sukhbir S. Uppal
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-1064-7

Other articles of this Issue 1/2006

Clinical Rheumatology 1/2006 Go to the issue

Original Article

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib

Original Article

Klinefelter’s syndrome and juvenile chronic arthritis

Case Report

First report of leprosy presenting as acute polyarthritis in the setting of type I downgrading lepra reaction

Letter

Infliximab as monotherapy in giant cell arteritis

Review

From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature

Case Report

Remitting seronegative symmetrical synovitis with pitting edema in leprosy
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits